Toshio Miyata, Charles van Ypersele de Strihou. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiotensin II Type 1 Receptor Blockers/therapeutic useAnimalsBiomedical Research/trendsClinical Medicine/trendsDiabetic Nephropathies/etiologyDiabetic Nephropathies/prevention & controlDiabetic Nephropathies/therapyDisease Models, AnimalHumansHyperglycemia/complicationsHyperglycemia/drug therapyHypertension/complicationsHypertension/drug therapyMiceObesity/complicationsObesity/diet therapyPioglitazonePlasminogen Activator Inhibitor 1/geneticsRatsRats, Inbred SHRThiazolidinediones
Substances: See more » Angiotensin II Type 1 Receptor BlockersPlasminogen Activator Inhibitor 1ThiazolidinedionesPioglitazone
Year: 2009 PMID: 19211649 DOI: 10.1093/ndt/gfp028
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN: 0931-0509 Impact factor: 5.992